Aman Chauhan, MD, is Director of NET Theranostics at UK Markey Cancer Center in Kentucky. A medical oncologist, Dr. Chauhan’s clinical interests include treating neuroendocrine tumors, including carcinoid tumors, high-grade neuroendocrine carcinomas, and small and non-small cell lung cancer. As Markey’s Director of NET Theranostics, Dr. Chauhan identifies NET patients who qualify for Lutathera® (Lutetium 177 DOTATATE) treatments for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Dr. Chauhan is also a member of the multidisciplinary medical team for the Pediatric Neuroendocrine Tumor Clinical and Research Program at the Kentucky Children’s Hospital.
Dr. Chauhan completed a Cancer Therapy Evaluation Program (CTEP) physician externship at the National Cancer institute (NCI) that focused on designing clinical trials and clinical research projects. He was selected to join NET Connect, an international organization that brings NET experts together and includes strategic support from a steering committee of established leaders in the field.
He is a member of the American Society of Clinical Oncology as well as the American Association of Cancer Research and the North American Neuroendocrine Tumor Society.
Among Dr. Chauhan’s recent articles are:
